The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery

Konkuk University Medical Center

Status and phase: Unknown; Phase 4

Conditions: Coronary Artery Disease

Treatments: Drug: Remimazolam Injection [Byfavo]

Study type: Interventional

Funder types: Other

Identifiers

NCT05041725

20210000-2

Details and patient eligibility

About

This study analyzes the impact of intraoperative Remimazolam infusion for postoperative sedation on the left ventricular global longitude strain (LV-GLS) patients undergoing cardiac surgery

Enrollment: 15 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• elective off-pump coronary artery bypass surgery

Exclusion criteria

• arrhythmia
• LV ejection fraction < 50 %
• preoperative inotropic support

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

remimazolam infusion

Experimental group

Description:

Intraoperative remimazolam infusion for postoperative sedation

Treatment:

Drug: Remimazolam Injection [Byfavo]